label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 171082164_2 | 171082164 | required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registr... |
1 | 171082164_3 | 171082164 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Ac... |
1 | 171082164_b0 | 171082164 | 2015 2015 2014 2014 2014 2014 2015 2014 2013
$ 307 24,519 $ (24,157) $ (0.76) $ (0.76)
$ 429 23,090 $ (22,976) $ (0.73) $ (0.73)
$ 278 18,313 $ (18,277) $ (0.59) $ (0.59)
$ 593 15,622 $ (15,202) $ (0.55) $ (0.55)
$ 2,013 15,118 $ (13,110) $ (0.48) $ (0.48)
$ 1,486 14,618 $ (13,182) $ (0.48) $ (0.48)
$ 15,121 $ ... |
1 | 171082164_b1 | 171082164 |
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 20, 2012
$ 0
$ 534,000 $ 676,000
40.00%
$ 0
0
500,000
100,000
2 years $ 500,000 250,000 $ 250,000 10.00%
40.00%
3,182,253 $ 26
400,000 $ 534,000 $ 676,000
18.00% 3,182,253
Quarterly Financial Information (Unaudited)
(Details) - USD ($) $ / s... |
1 | 171086174_0 | 171086174 | NXP Semiconductors N.V.
Form 20-F
Filed on 26-Feb-2016 Period 31-Dec-2015 Accession number: 0001193125-16-481954
Included Items
1. 20-F 2. EX-4.10 3. EX-10.22 4. EX-10.25 5. EX-10.26 6. EX-10.27 7. EX-10.28 8. EX-12.1 9. EX-12.2 10. EX-13.1 11. EX-13.2 12. EX-21.1 13. EX-23 14. XBRL (render)
Table of Contents
As f... |
1 | 171086174_1 | 171086174 |
For the fiscal year ended December 31, 2015 OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
For the transition period fr... |
1 | 171086174_2 | 171086174 | 12(b) of the Act.
Title of each class
Common shares--par value euro (EUR) 0.20 per share
Name of each exchange on which registered
The NASDAQ Global Select Market
Securities registered or to be registered pursuant to Section 12(g) of the Act.
None
(Title of class)
Securities for which there is a reporting obligat... |
1 | 171086174_3 | 171086174 | of 1934. ¨ Yes x No
Note--Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed b... |
1 | 171086174_b0 | 171086174 | 360
116
115
Netherlands [Member]
Segment Reporting Information [Line Items]
Revenue
177
171
146
Property, plant and equipment
161
169
180
Taiwan [Member]
Segment Reporting Information [Line Items]
Revenue
78
96
98
Property, plant and equipment
160
138
91
United States [Member]
Segment Reporting ... |
1 | 171086174_b1 | 171086174 |
Translation differences and other changes
(27)
Accumulated Impairment [Member]
Goodwill [Line Items]
Translation differences and other changes
21
Accumulated Impairment [Member] | HPMS [Member]
Goodwill [Line Items]
Translation differences and other changes
18
Accumulated Impairment [Member] | SP [Member]
... |
1 | 171086656_0 | 171086656 | ROWAN COMPANIES PLC
Form 10-K
Filed on 26-Feb-2016 Period 31-Dec-2015 Accession number: 0000085408-16-000014
Included Items
1. 10-K 2. EX-10.30: EXHIBIT 10.30 3. EX-21: EXHIBIT 21 4. EX-23: EXHIBIT 23 5. EX-31.1: EXHIBIT 31.1 6. EX-31.2: EXHIBIT 31.2 7. EX-32.1: EXHIBIT 32.1 8. EX-32.2: EXHIBIT 32.2 9. XBRL (render)
... |
1 | 171086656_1 | 171086656 | transition period from __________ to __________ Commission File Number: 1-5491
Rowan Companies plc
(Exact name of registrant as specified in its charter)
England and Wales (State or other jurisdiction of incorporation or organization)
98-1023315 (I.R.S. Employer Identification No.)
2800 Post Oak Boulevard, Suite 5... |
1 | 171086656_2 | 171086656 | check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the ... |
1 | 171086656_3 | 171086656 | definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Large accelerated filer þ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 o... |
1 | 171086656_b0 | 171086656 | plant and equipment
0
0
Advances on subsidiary note receivable
481,300
Collections on subsidiary note receivable
(540,083)
Investments in consolidated subsidiaries
37,454 105,261
(1,274,613) (1,521,313)
0
0
(12,066,161) (12,009,696)
0
0
0
0
0
0
0
0
0
0
(1,274,613) (1,521,313)
0
0
(477,954) (4... |
1 | 171086656_b1 | 171086656 | OSS)
52,354 251,233
Statement of Comprehensive Income [Abstract]
NET INCOME (LOSS)
52,354 251,233
OTHER COMPREHENSIVE INCOME (LOSS):
Net changes in pension and other postretirement plan assets and benefit obligations recognized in other comprehensive income, net of income taxes
(6,964) 87,293
Net reclassificati... |
1 | 171086679_0 | 171086679 | XL GROUP LTD
Form 10-K
Filed on 26-Feb-2016 Period 31-Dec-2015 Accession number: 0000875159-16-000097
Included Items
1. 10-K 2. EX-10.58: EXHIBIT 10.58 3. EX-10.59: EXHIBIT 10.59 4. EX-10.60: EXHIBIT 10.60 5. EX-10.61: EXHIBIT 10.61 6. EX-10.62: EXHIBIT 10.62 7. EX-10.63: EXHIBIT 10.63 8. EX-12: EXHIBIT 12 9. EX-21: ... |
1 | 171086679_1 | 171086679 | 1934
For the fiscal year ended December 31, 2015
OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to Commission file number 1-10804
XL GROUP
Public Limited Company
(Exact name of registrant as specified in its charter)
Ireland (State or oth... |
1 | 171086679_2 | 171086679 | 5% Subordinated Notes due 2045
Name of each exchange on which registered New York Stock Exchange New York Stock Exchange New York Stock Exchange New York Stock Exchange New York Stock Exchange New York Stock Exchange
SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: None
Indicate by check mark if the regist... |
1 | 171086679_3 | 171086679 | T (§232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best ... |
1 | 171086679_b0 | 171086679 | other companies, premiums earned
309,916
333,436
324,342
Net amount, premiums earned
$ 62,241 $ 177,632 $ 295,422
Percentage of amount assumed to net
497.90% 187.70% 109.80%
[1] Represents the sum face value outstanding of the in force life reinsurance policies.
Schedule VI - Supplementary Information Concer... |
1 | 171086679_b1 | 171086679 | ,425 $ 5,895,070 $ 6,309,521
Percentage of amount assumed to net
45.90%
45.40%
42.60%
Property and casualty operations
Total premiums earned:
Gross amount, premiums earned
$ 7,717,173 $ 5,173,403 $ 4,966,207
Ceded to other companies, premiums earned
3,018,410 1,799,294 1,315,369
Assumed from other companies,... |
1 | 171087078_0 | 171087078 | SYNTEL INC
Form 10-K
Filed on 26-Feb-2016 Period 31-Dec-2015 Accession number: 0001193125-16-482419
Included Items
1. 10-K 2. EX-10.22 3. EX-10.23 4. EX-21 5. EX-23 6. EX-31.1 7. EX-31.2 8. EX-31.3 9. EX-32 10. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... |
1 | 171087078_1 | 171087078 | Michigan
(Address of principal executive offices)
Registrant's telephone number, including area code: (248) 619-2800
Securities registered pursuant to Section 12(b) of the Act:
48083
(Zip Code)
Title of Class
Common Stock, no par value
Name of Exchange on Which Registered
The NASDAQ Global Select Market
Securities... |
1 | 171087078_2 | 171087078 | has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes x No ¨
Indic... |
1 | 171087078_3 | 171087078 | rant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
The aggregate market value of the Common Stock held by non-affiliates of the Registrant as of the last business day of the Registrant's most recently completed second fiscal quarter, June 30, 2015, based on the last sale price of $47.48... |
1 | 171087078_b0 | 171087078 | ]
Ownership percentage in subsidiary
49.00%
Financial Assets Measured at Fair Value on Recurring Basis
(Detail) - USD ($) $ in Millions
Dec. 31, 2015 Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short term investments Available for sale securities
$ ... |
1 | 171087078_b1 | 171087078 | Ended Dec. 31, 2015 Dec. 31, 2014
Quarterly Financial Data [Line Items]
Stock split
Two-for-one stock split
Stock split conversion ratio
2
Consolidation of Variable Interest Entity - Additional Information (Detail) - Person
12 Months Ended Dec. 31, 2015 Dec. 31, 2014 Dec. 31, 2013
State Street Bank
Revenue, ... |
1 | 171089270_0 | 171089270 | Horizon Pharma Plc
Form 10-K
Filed on 29-Feb-2016 Period 31-Dec-2015 Accession number: 0001564590-16-013652
Included Items
1. 10-K 2. EX-2.4 3. EX-10.3 4. EX-10.60 5. EX-10.61 6. EX-10.62 7. EX-10.63 8. EX-10.64 9. EX-10.66 10. EX-10.67 11. EX-10.68 12. EX-21.1 13. EX-23.1 14. EX-31.1 15. EX-31.2 16. EX-32.1 17. EX-3... |
1 | 171089270_1 | 171089270 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission File Number 001-35238
HORIZON PHARMA PUBLIC LIMITED COMPANY
(Exact name of Registrant as specified in its charter)
Ireland
(State or other jurisdiction of incorporation or organizat... |
1 | 171089270_2 | 171089270 | Yes x No o.
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the pr... |
1 | 171089270_3 | 171089270 | amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
Large accelerated filer
x
Non-accelerated filer
o (Do not check if a smaller reporting company)
Indicate by check mark whether ... |
1 | 171089270_b0 | 171089270 | , 2015
Subsequent Event [Line Items]
Transaction fees for legal, advisory and other fees
$ 1.9
Subsequent Event [Member]
Subsequent Event [Line Items]
Cash consideration
$ 510.0
Schedule II - Valuation and Qualifying Accounts (Detail) -
USD ($) $ in Thousands
12 Months Ended Dec. 31, 2015 Dec. 31, 2014 Dec. 3... |
1 | 171089270_b1 | 171089270 | 71,161 61,482 41,252 44,307 537,542 218,202 59,391
(33,173) 4,764 8,983 (11,961) (7,100) 1,587 $ 55,372 $ (8,491) $ (42,854)
$ 31,814
$ (19,553)
$ (31,647)
$ 2,063
$
$
(27,769) (206,250)
$ (0.27) $ 0.03 $ (0.38) $ (3.07)
$ 0.15 $ 0.02 $ 0.21 $ (0.16)
$ 0.27 $ (3.15) $ (2.34)
$ 0.15 $ 0.02 $ 0.20 $ (0.16)
... |
1 | 171089328_0 | 171089328 | Criteo S.A.
Form 10-K
Filed on 29-Feb-2016 Period 31-Dec-2015 Accession number: 0001576427-16-000149
Included Items
1. 10-K 2. EX-4.2: EXHIBIT 4.2 CREDIT FACILTY 3. EX-4.3: EXHIBIT 4.3 DEBT 4. EX-10.7: EXHIBIT 10.7 SUMMARY BSA 5. EX-10.13: EXHIBIT 10.13 PERFORMANCE 6. EX-10.14: EXHIBIT 10.14 TIME-BASED 7. EX-10.15: E... |
1 | 171089328_1 | 171089328 | IT 32.1 SOX CEO
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Fiscal Year Ended December 31, 2015
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES... |
1 | 171089328_2 | 171089328 | representing one ordinary share, nominal value 0.025 per share
Ordinary shares, nominal value 0.025 per share* (Title of class)
* Not for trading, but only in connection with the registration of the American Depositary Shares.
Nasdaq Global Select Market Nasdaq Global Select Market * (Name of exchange on which regist... |
1 | 171089328_3 | 171089328 | corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark if disclosure of delinquent fil... |
1 | 171089328_b0 | 171089328 | weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information and
(b) Any fraud, whether or not material, that involves management or other employees who have a ... |
1 | 171089328_b1 | 171089328 | period in which this report is being prepared
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial st... |
1 | 171091354_0 | 171091354 | WHITEWAVE FOODS Co
Form 10-K
Filed on 29-Feb-2016 Period 31-Dec-2015 Accession number: 0001555365-16-000038
Included Items
1. 10-K 2. EX-3.1: EXHIBIT 3.1 3. EX-10.23: EXHIBIT 10.23 4. EX-10.24: EXHIBIT 10.24 5. EX-10.25: EXHIBIT 10.25 6. EX-21: EXHIBIT 21 7. EX-23: EXHIBIT 23 8. EX-31.1: EXHIBIT 31.1 9. EX-31.2: EXHI... |
1 | 171091354_1 | 171091354 | SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For The Fiscal Year Ended December 31, 2015
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from
to
Commission File Number 001-35708
The WhiteWave Foods Company
(Exact name of Regi... |
1 | 171091354_2 | 171091354 | Indicate by check mark if the registrant is a well-known seasoned-issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x
Indicate by check mark whether the registrant (1) has... |
1 | 171091354_3 | 171091354 | , and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerat... |
1 | 171091354_b0 | 171091354 | (17,020)
3,553 84
0
0 0 0
0 0 3,637 3,182 37,783 62,649
Cash and cash equivalents, end of year
$ 36,328 $ 49,716 $ 100,432
Quarterly Results of Operations (unaudited)
(Detail) - USD ($) $ / shares in Units, $ in
Thousands Quarterly Financial Information Disclosure [Abstract] Net sales
Gross profit Net income Net i... |
1 | 171091354_b1 | 171091354 | provided by (used in) financing activities
553,915
Effect of exchange rate changes on cash and cash equivalents
(5,361)
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
(13,388)
Cash and cash equivalents, beginning of year
49,716
230,511
(3,000) (798,446) (191,160) 0 464
(992,142)
762,526
0 0 (1,044) 0 0 0 0 0... |
1 | 171092791_0 | 171092791 | Medidata Solutions, Inc.
Form 10-K
Filed on 29-Feb-2016 Period 31-Dec-2015 Accession number: 0001453814-16-000174
Included Items
1. 10-K: FORM 10-K 2. EX-21.1: SUBSIDIARIES OF MEDIDATA
SOLUTIONS, INC. 3. EX-23.1: CONSENT OF DELOITTE & TOUCHE
LLP 4. EX-31.1: CERTIFICATION OF CEO PURSUANT
TO RULE 13A-14(A) OR 15D-14(A)... |
1 | 171092791_1 | 171092791 | BRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________
FORM 10-K
_____________________________________
ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31,... |
1 | 171092791_2 | 171092791 | Securities registered under Section 12(b) of the Exchange Act:
Title of each class
Name of each exchange on which registered
Common Stock, par value $0.01 per share
The NASDAQ Stock Market LLC
Securities registered under Section 12(g) of the Exchange Act: None Indicate by check mark if the registrant is a well-kno... |
1 | 171092791_3 | 171092791 | -T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ý Yes ¨ No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to th... |
1 | 171092791_b0 | 171092791 | 76,961 80,320 75,173 70,264 67,060 65,001 62,249 55,841 302,718 250,151 206,940
2014 wire transaction loss
(904) (4,880) 0
0
0
[1] (5,784) [1] 0
[1]
Operating income
9,675 11,104 4,987 3,466 9,075 3,575 7,140 274 29,232 20,064 23,888
Net income
$ 6,816 $ 4,681 $ 1,513 $ 157
$ 5,450 $ 161
$ 2,296
$ (1,815)
... |
1 | 171092791_b1 | 171092791 |
Change in control agreements, period following change in control for payments to be made upon involuntary termination of employment
2 years
Change in control agreements, period for continuation of health benefits
12 months
Dec. Dec. 31, 31, 2014 2013
$ 1.7 $ 1.4
Unaudited Selected Quarterly Financial Data (Deta... |
1 | 171092951_0 | 171092951 | Endo International Plc
Form 10-K
Filed on 29-Feb-2016 Period 31-Dec-2015 Accession number: 0001593034-16-000051
Included Items
1. 10-K 2. EX-4.7: SUPPLEMENTAL INDENTURE 5.75%
2022 NOTES 3. EX-4.9: SUPPLEMENTAL INDENTURE 7.25%
2022 NOTES 4. EX-4.12: SUPPLEMENTAL INDENTURE 2023
NOTES 5. EX-4.15: SUPPLEMENTAL INDENTURE ... |
1 | 171092951_1 | 171092951 | LLP 12. EX-23.2: CONSENT OF DELOITTE AND TOUCHE LLP 13. EX-24.1: POWER OF ATTORNEY 14. EX-31.1: CEO SECTION 302 CERTIFICATION 15. EX-31.2: CFO SECTION 302 CERTIFICATION
16. EX-32.1: CEO SECTION 906 CERTIFICATION
17. EX-32.2: CFO SECTION 906 CERTIFICATION
18. XBRL (render)
Table of Contents
UNITED STATES SECURITIE... |
1 | 171092951_2 | 171092951 | INTERNATIONAL PLC
(Exact Name of Registrant as Specified in Its Charter)
____________________________________________________________________________________________
Ireland (State or other jurisdiction of incorporation or organization)
68-0683755 (I.R.S. Employer Identification Number)
First Floor, Minerva House, ... |
1 | 171092951_3 | 171092951 |
Yes o No x
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months Yes x No o (or for such shorter period that the registrant was required to file such reports), and (2) has been subject... |
1 | 171092951_b0 | 171092951 | 900 923,600 70,200 7,000 22,500
1,140,709 22,542 32,011
Inventory Step Up Cost
117,700 42,900 48,900 39,900 25,500 17,400 19,100 3,600 232,461 65,582 0
Severance costs
55,200 22,700 5,800 41,800 8,700 7,500 11,400 (1,900) 60,200 14,400 35,200
Legal Fees
17,200
6,900 13,000 35,000 3,100 4,000
Loss on extinguish... |
1 | 171092951_b1 | 171092951 | 02) $ (1.35) $ (0.43) $ (0.34) $ (1.59) $ 0.13 $ (3.41) $ (7.59) $ (4.60) $ (5.72)
Weighted average shares--Basic (shares)
224,147 209,274 185,328 169,653 153,772 153,309 152,368 128,135 197,100 146,896 113,295
Weighted average shares--Diluted (shares)
225,321 209,274 185,328 176,825 159,213 158,975 163,369 128,135... |
1 | 171093605_0 | 171093605 | Frank's International N.V.
Form 10-K
Filed on 29-Feb-2016 Period 31-Dec-2015 Accession number: 0001575828-16-000041
Included Items
1. 10-K 2. EX-10.12: EXHIBIT 10.12 3. EX-10.13: EXHIBIT 10.13 4. EX-10.14: EXHIBIT 10.14 5. EX-10.20: EXHIBIT 10.20 6. EX-10.21: EXHIBIT 10.21 7. EX-10.22: EXHIBIT 10.22 8. EX-10.36: EXHI... |
1 | 171093605_1 | 171093605 | HIBIT 32.1 16. EX-32.2: EXHIBIT 32.2 17. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 10-K (Mark One)
þ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended December 31, 2015
OR
¨ Transition Report Pursuant to Sect... |
1 | 171093605_2 | 171093605 | urities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of exchange on which registered
Common Stock, 0.01 par value
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defin... |
1 | 171093605_3 | 171093605 | .405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not b... |
1 | 171093605_b0 | 171093605 | (in dollars per share)
3 Months Ended
12 Months Ended
Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31, Dec. 31, Dec. 31, 2015 2015 2015 2015 2014 2014 2014 2014 2015 2014 2013
$
202,976
$ 239,883
$ 254,304
$
277,437
$
319,020
$ 296,183
$ 272,937
$
264,492
$
974,600
$ 1... |
1 | 171093605_b1 | 171093605 |
$
$
$
202,976 239,883 254,304 277,437 319,020 296,183 272,937 264,492 974,600 1,152,632 1,077,722
624,959
580,142
624,959 580,142 511,199
336,870
266,111
530,133 573,773 542,562 336,870 266,111
314,173 385,064 310,603
56,515 55,021 78,019
55,995 77,952 63,709
17,784 60,822 $ 82,829
$ 288,089
$ 314,031
... |
1 | 171094550_0 | 171094550 | Atlantica Yield Plc
Form 20-F
Filed on 01-Mar-2016 Period 31-Dec-2015 Accession number: 0001140361-16-055669
Included Items
1. 20-F: ABENGOA YIELD PLC 20-F 12-31-2015 2. EX-4.6: EXHIBIT 4.6 3. EX-4.7: EXHIBIT 4.7 4. EX-4.13: EXHIBIT 4.13 5. EX-8.1: EXHIBIT 8.1 6. EX-12.1: EXHIBIT 12.1 7. EX-12.2: EXHIBIT 12.12 8. EX-... |
1 | 171094550_1 | 171094550 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2015
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
... |
1 | 171094550_2 | 171094550 | United Kingdom TW8 9DF
Tel: + 44 203 547 8055
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class Ordinary Shares, nominal value $0.10 per share
Name of each exchange on which reg... |
1 | 171094550_3 | 171094550 | (d) of the Securities Exchange Act of 1934. Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report... |
1 | 171094550_b0 | 171094550 | Officer
Exhibit 13.1 Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2015 (the "Annual Report") for the purpose... |
1 | 171094550_b1 | 171094550 | effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation and
(d) Disclosed in this report any change in the Company's inte... |
1 | 171095350_0 | 171095350 | Oxford Immunotec Global PLC
Form 10-K
Filed on 01-Mar-2016 Period 31-Dec-2015 Accession number: 0001437749-16-026453
Included Items
1. 10-K: FORM 10-K 2. EX-10.36: EXHIBIT 10.36 3. EX-10.39: EXHIBIT 10.39 4. EX-10.41: EXHIBIT 10.41 5. EX-10.43: EXHIBIT 10.43 6. EX-10.44: EXHIBIT 10.44 7. EX-21.1: EXHIBIT 21.1 8. EX-2... |
1 | 171095350_1 | 171095350 | PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2015 OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission File Number 001-36200
OXFORD IMMUNOTEC GLOBAL PLC
(Exact nam... |
1 | 171095350_2 | 171095350 | DAQ Global Market
Securities registered pursuant to Section 12(g) of the Act None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) o... |
1 | 171095350_3 | 171095350 | filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the registr... |
1 | 171095350_b0 | 171095350 | ,399) $ (9,669)
Net loss per share--basic and diluted (in dollars per share)
$ (1.29)
$ (2.52)
Weighted average shares outstanding--basic and diluted (in shares) 17,310,148 3,830,837
Weighted average shares outstanding--basic and diluted (in shares) 17,310,148 3,830,837
Note 18 - Restructuring (Details Textual)
... |
1 | 171095350_b1 | 171095350 | Thousands
Jul. 31, 2014 USD ($)
Boulder Diagnostics Inc [Member]
Assets acquired:
Cash
$ 8
Accounts receivable
15
Inventory
40
Property and equipment
359
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets 2,627
Total assets acquired
3... |
1 | 171096935_0 | 171096935 | PACIFIC DRILLING S.A.
Form 20-F
Filed on 01-Mar-2016 Period 31-Dec-2015 Accession number: 0001517342-16-000062
Included Items
1. 20-F 2. EX-1.1: EXHIBIT 1.1 3. EX-4.08: EXHIBIT 4.08 4. EX-4.14: EXHIBIT 4.14 5. EX-8.1: EXHIBIT 8.1 6. EX-12.1: EXHIBIT 12.1 7. EX-12.2: EXHIBIT 12.2 8. EX-13.1: EXHIBIT 13.1 9. EX-13.2: E... |
1 | 171096935_1 | 171096935 | EXCHANGE ACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2015
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 (d) O... |
1 | 171096935_2 | 171096935 | 883
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
Common shares, $0.01 par value per share
Name of each exchange on which registered
New York Stock Exchange
Securities regist... |
1 | 171096935_3 | 171096935 | icate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements ... |
1 | 171096935_b0 | 171096935 | 2013
Segment Reporting [Abstract]
Number of reportable segment
1
Operating Segments | Sales | Nigeria
Segment Reporting Information [Line Items]
Percentage of revenue earned by geographical area 60.30%
60.20%
52.10%
Operating Segments | Sales | Gulf of Mexico
Segment Reporting Information [Line Items]
Perce... |
1 | 171096935_b1 | 171096935 | .9
Concentrations of Credit and Market Risk - Percentage of
Revenues Earned from Customers (Detail)
12 Months Ended Dec. 31, 2015 Dec. 31, 2014 Dec. 31, 2013
Sales | Chevron
Concentration Risk [Line Items]
Concentration risk percentage
81.20%
67.40%
55.60%
Sales | Total
Concentration Risk [Line Items]
Conce... |
1 | 171101312_0 | 171101312 | Royal Ahold Delhaize
Form 20-F
Filed on 03-Mar-2016 Period 03-Jan-2016 Accession number: 0001193125-16-490286
Included Items
1. 20-F 2. EX-12.01 3. EX-12.02 4. EX-13.01 5. EX-13.02
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 20-F
(Mark One)
¨ REGISTRATION STATEM... |
1 | 171101312_1 | 171101312 | TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
Commission file number: 001-12510
Koninklijke Ahold N.V.
(Exact name of registrant as specified in its charter)
Royal Ahold
(Translation of registrant's name into English)
The Netherlands
(Jurisdiction o... |
1 | 171101312_2 | 171101312 | which there is a reporting obligation pursuant to Section 15(d) of the Act: Ordinary Shares, nominal value 0.01 per share
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report: 818,471,229
Indicate by check mark i... |
1 | 171101312_3 | 171101312 | Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ¨ No ¨
Indicate by check mark whether the registrant is a large accelerated fi... |
1 | 171101312_b0 | 171101312 | knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report.
Date: March 2, 2016
/s/ Jeff Carr Name: Jeff Carr Tit... |
1 | 171101312_b1 | 171101312 | contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report and
3. Based on my knowledge, the financial statements, and other... |
1 | 171105057_0 | 171105057 | Orion Engineered Carbons S.A.
Form 20-F
Filed on 04-Mar-2016 Period 31-Dec-2015 Accession number: 0001609804-16-000057
Included Items
1. 20-F 2. EX-8.1: EXHIBIT 8.1 3. EX-12.1: EXHIBIT 12.1 4. EX-12.2: EXHIBIT 12.2 5. EX-13.1: EXHIBIT 13.1 6. EX-13.2: EXHIBIT 13.2 7. EX-15.1: EXHIBIT 15.1
UNITED STATES SECURITIES A... |
1 | 171105057_1 | 171105057 |
or o Shell company report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission file number: 001- 36563
ORION ENGINEERED CARBONS S.A.
(Exact Name of Registrant as Specified in its Charter)
N/A
(Translation of Registrant's Name into English)
Grand Duchy of Luxembourg
(Jurisdiction of Inco... |
1 | 171105057_2 | 171105057 | pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.
59,635,126 common shares, no par value
Indicate by check mark if the registrant is a well-known seasoned issuer... |
1 | 171105057_3 | 171105057 | 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such sho... |
1 | 171105057_b0 | 171105057 | knowledge, the Company's Annual Report on Form 20-F for the year ended December 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the f... |
1 | 171105057_b1 | 171105057 | any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting and
5. The company's other certifying officer and I have... |
1 | 171105149_0 | 171105149 | SMITH & NEPHEW PLC
Form 20-F
Filed on 04-Mar-2016 Period 31-Dec-2015 Accession number: 0001193125-16-492258
Included Items
1. 20-F 2. EX-4.(C)(XIX): EX-4(C)(XIX) 3. EX-4.(C)(XX): EX-4(C)(XX) 4. EX-4.(C)(XXI): EX-4(C)(XXI) 5. EX-4.(C)(XXII): EX-4(C)(XXII) 6. EX-8 7. EX-12.A 8. EX-12.B 9. EX-13.A 10. EX-15.1 11. EX-15.... |
1 | 171105149_1 | 171105149 | ACT OF 1934
or
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2015 or
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
or
¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC... |
1 | 171105149_2 | 171105149 | registered or to be registered pursuant to Section 12(g) of the Act: None.
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None.
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the ... |
1 | 171105149_3 | 171105149 | the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to subm... |
1 | 171105149_b0 | 171105149 | an opinion on these financial statements based on our audits.
Auditor's responsibility We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the f... |
1 | 171105149_b1 | 171105149 | 168544) pertaining to the Smith & Nephew Global Share Plan 2010 11. Registration Statement (Form S-8 No. 333-199117) pertaining to the Smith & Nephew Global Share Plan 2010
of our report dated February 25, 2015, with respect to the consolidated financial statements of Smith & Nephew plc for each of the two years in the... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.